# Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes

> **NCT01935804** · PHASE2 · COMPLETED · sponsor: **King Abdulaziz University** · enrollment: 440 (estimated)

## Conditions studied

- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Glucose Metabolism Disorders

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01935804
- **Lead sponsor:** King Abdulaziz University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2014-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01935804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01935804, "Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01935804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*